|
Market Closed -
Nasdaq
15:57:30 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 213.38 USD | -0.14% |
|
+0.30% | +16.83% |
| 08-12 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 08-12 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -80.19x | 141.16x | 2.91x | 11.36x | -82.03x | -82.05x | -.--% | 11.19B | ||
| 18.61x | 2.45x | 4.54x | 4.33x | 10.21x | 12.02x | 0.49% | 80.23B | ||
| 37.7x | 7.75x | 0.7x | 12.88x | 24.51x | 28.67x | -.--% | 50.64B | ||
| 21.26x | 3.36x | 0.98x | 4.7x | 13.43x | 16.69x | 0.69% | 46.87B | ||
| -51.83x | 2.88x | 0.4x | 3.58x | 10.59x | 12.35x | 2.95% | 46.34B | ||
| 37.28x | 1.68x | -1.04x | 3.44x | 13.12x | 14.3x | -.--% | 31B | ||
| -7.38x | 4.47x | -0.41x | 10.27x | -6.63x | -6.18x | -.--% | 25.28B | ||
| 52.93x | 4.1x | -0.82x | 3.38x | 26.22x | 23.34x | -.--% | 24.36B | ||
| 69.87x | 6.26x | 0.48x | 6.7x | 44.75x | 54.08x | -.--% | 20.81B | ||
| 23.08x | 3.39x | 0.02x | 4.97x | 12.94x | 17.99x | -.--% | 16.08B | ||
| -29.07x | -5.8x | 1.06x | 16.49x | -43.97x | -44.58x | -.--% | 15.61B | ||
| 73.74x | 30.14x | 0.68x | 44.41x | 64.49x | 66.96x | 0.15% | 15.47B | ||
| 22.51x | - | 0.34x | 3.87x | 15.12x | 18.24x | -.--% | 13.04B | ||
| 43.83x | - | 4.05x | - | - | - | -.--% | 9.83B | ||
| -71.29x | - | -2.55x | - | - | - | - | 7.44B | ||
| 12.55x | 1.17x | 0.38x | 1.88x | 7.56x | 10.06x | 2.79% | 6.86B | ||
| 32.27x | - | 1.58x | 8.76x | 23.25x | 27.77x | 0.32% | 6.62B | ||
| 67.48x | 4.77x | -0.87x | - | - | - | - | 6.43B | ||
| 60.81x | 7.31x | 0.89x | 5.92x | 32.75x | 44.11x | -.--% | 5.99B | ||
| -114.36x | - | 7.58x | - | - | - | -.--% | 5.64B | ||
| Average | 10.99x | 14.34x | 1.04x | 9.18x | 10.39x | 13.36x | 0.41% | 22.29B | |
| Weighted average by Cap. | 14.62x | 8.35x | 1.24x | 7.88x | 12.46x | 14.93x | 0.54% |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















